Hepatic Steatosis: A Pandemic Disease Causing Serious Secondary Diseases

Dtsch Arztebl Int. 2026 Sep 18;123(19):arztebl.m2026.0074. doi: 10.3238/arztebl.m2026.0074. Online ahead of print.ABSTRACTBACKGROUND: At least one-quarter of the world's population now suffers from hepatic steatosis (fatty liver disease), which, in current terminology, is called metabolic dysfunctio

A Ali Canbay

Multi-omics profiling reveals epidermal growth factor as a potential biomarker and therapeutic target in lupus nephritis and ANCA-associated vasculitis with rapidly progressive glomerulonephritis

PLoS One. 2026 May 29;21(5):e0349307. doi: 10.1371/journal.pone.0349307. eCollection 2026.ABSTRACTThe kidney is a primary target organ in systemic lupus erythematosus (SLE) and ANCA-associated vasculitis (AAV), which frequently manifest as lupus nephritis (LN) and renal AAV, respectively. A severe a

M Mengli Xu